• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

T细胞疫苗诱导的人抗独特型T细胞对TCR高变区的优先识别

Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination.

作者信息

Zang Y C, Hong J, Rivera V M, Killian J, Zhang J Z

机构信息

Multiple Sclerosis Research Laboratory, Department of Neurology and Baylor-Methodist Multiple Sclerosis Center, Baylor College of Medicine, Houston, TX 77030, USA.

出版信息

J Immunol. 2000 Apr 15;164(8):4011-7. doi: 10.4049/jimmunol.164.8.4011.

DOI:10.4049/jimmunol.164.8.4011
PMID:10754292
Abstract

T cell responses to myelin basic protein (MBP) are potentially involved in the pathogenesis of multiple sclerosis (MS). Immunization with irradiated MBP-reactive T cells (T cell vaccination) induces anti-idiotypic T cell responses that suppress circulating MBP-reactive T cells. This T cell-T cell interaction is thought to involve the recognition of TCR expressed on target T cells. The study was undertaken to define the idiotypic determinants responsible for triggering CD8+ cytotoxic anti-idiotypic T cell responses by T cell vaccination in patients with MS. A panel of 9-mer synthetic TCR peptides corresponding to complementarity-determining region 2 (CDR2) and CDR3 of the immunizing MBP-reactive T cell clones were used to isolate anti-idiotypic T cell lines from immunized MS patients. The resulting TCR-specific T cell lines expressed exclusively the CD8 phenotype and recognized preferentially the CDR3 peptides. CDR3-specific T cell lines were found to lyze specifically autologous immunizing MBP-reactive T cell clones. The findings suggest that CDR3-specific T cells represented anti-idiotypic T cell population induced by T cell vaccination. In contrast, the CDR2 peptides were less immunogenic and contained cryptic determinants as the CDR2-specific T cell lines did not recognize autologous immunizing T cell clones from which the peptide sequence was derived. The study has important implications in our understanding of in vivo idiotypic regulation of autoimmune T cells and the regulatory mechanism underlying T cell vaccination.

摘要

T细胞对髓鞘碱性蛋白(MBP)的反应可能参与了多发性硬化症(MS)的发病机制。用经辐照的MBP反应性T细胞进行免疫接种(T细胞疫苗接种)可诱导抗独特型T细胞反应,从而抑制循环中的MBP反应性T细胞。这种T细胞与T细胞的相互作用被认为涉及对靶T细胞上表达的TCR的识别。本研究旨在确定在MS患者中通过T细胞疫苗接种触发CD8+细胞毒性抗独特型T细胞反应的独特型决定簇。使用一组与免疫MBP反应性T细胞克隆的互补决定区2(CDR2)和CDR3相对应的9聚体合成TCR肽,从免疫的MS患者中分离抗独特型T细胞系。所得的TCR特异性T细胞系仅表达CD8表型,并优先识别CDR3肽。发现CDR3特异性T细胞系可特异性裂解自体免疫MBP反应性T细胞克隆。这些发现表明,CDR3特异性T细胞代表了由T细胞疫苗接种诱导的抗独特型T细胞群体。相比之下,CDR2肽的免疫原性较低,并且含有隐蔽决定簇,因为CDR2特异性T细胞系不能识别其肽序列所源自的自体免疫T细胞克隆。该研究对于我们理解自身免疫性T细胞的体内独特型调节以及T细胞疫苗接种的调节机制具有重要意义。

相似文献

1
Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination.T细胞疫苗诱导的人抗独特型T细胞对TCR高变区的优先识别
J Immunol. 2000 Apr 15;164(8):4011-7. doi: 10.4049/jimmunol.164.8.4011.
2
Human anti-idiotypic T cells induced by TCR peptides corresponding to a common CDR3 sequence motif in myelin basic protein-reactive T cells.由与髓鞘碱性蛋白反应性T细胞中常见的互补决定区3(CDR3)序列基序相对应的T细胞受体(TCR)肽诱导产生的人抗独特型T细胞。
Int Immunol. 2003 Sep;15(9):1073-80. doi: 10.1093/intimm/dxg105.
3
Reactivity and regulatory properties of human anti-idiotypic antibodies induced by T cell vaccination.T细胞疫苗诱导的人抗独特型抗体的反应性和调节特性
J Immunol. 2000 Dec 15;165(12):6858-64. doi: 10.4049/jimmunol.165.12.6858.
4
Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes.多发性硬化症中针对T细胞受体肽的免疫反应。III. 来自疾病相关T细胞受体BV基因的互补决定区2肽的优先免疫原性。
J Immunol. 1998 Jul 15;161(2):1034-44.
5
A common TCR V-D-J sequence in V beta 13.1 T cells recognizing an immunodominant peptide of myelin basic protein in multiple sclerosis.在多发性硬化症中识别髓鞘碱性蛋白免疫显性肽段的Vβ13.1 T细胞中的一种常见TCR V-D-J序列。
J Immunol. 1999 Sep 15;163(6):3530-8.
6
Diversity of the anti-T-cell receptor immune response and its implications for T-cell vaccination therapy of multiple sclerosis.抗T细胞受体免疫反应的多样性及其对多发性硬化症T细胞疫苗治疗的意义。
Brain. 1998 Aug;121 ( Pt 8):1395-407. doi: 10.1093/brain/121.8.1395.
7
In vivo clonotypic regulation of human myelin basic protein-reactive T cells by T cell vaccination.
J Immunol. 1995 Dec 15;155(12):5868-77.
8
Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis.多发性硬化症中CD8 + 细胞毒性T细胞对髓鞘碱性蛋白的反应增强。
J Immunol. 2004 Apr 15;172(8):5120-7. doi: 10.4049/jimmunol.172.8.5120.
9
Human CD8+ TCR-alpha beta(+) and TCR-gamma delta(+) cells modulate autologous autoreactive neuroantigen-specific CD4+ T-cells by different mechanisms.人类CD8+TCR-αβ(+)和TCR-γδ(+)细胞通过不同机制调节自身自体反应性神经抗原特异性CD4+T细胞。
J Neuroimmunol. 1997 Dec;80(1-2):47-64. doi: 10.1016/s0926-9851(97)00020-7.
10
Regulation of NOD mouse autoimmune diabetes by T cells that recognize a TCR CDR3 peptide.识别TCR CDR3肽的T细胞对NOD小鼠自身免疫性糖尿病的调节作用。
Int Immunol. 1999 Jun;11(6):957-66. doi: 10.1093/intimm/11.6.957.

引用本文的文献

1
Recent Advances in Antigen-Specific Immunotherapies for the Treatment of Multiple Sclerosis.用于治疗多发性硬化症的抗原特异性免疫疗法的最新进展
Brain Sci. 2020 May 29;10(6):333. doi: 10.3390/brainsci10060333.
2
Immune Response Regulation by Antigen Receptors' Clone-Specific Nonself Parts.抗原受体克隆特异性非自身部分对免疫反应的调节
Front Immunol. 2018 Jun 25;9:1471. doi: 10.3389/fimmu.2018.01471. eCollection 2018.
3
A Possible Role for Idiotype/Anti-idiotype B-T Cell Interactions in Maintaining Immune Memory.独特型/抗独特型B细胞与T细胞相互作用在维持免疫记忆中的可能作用。
Front Immunol. 2017 Apr 6;8:409. doi: 10.3389/fimmu.2017.00409. eCollection 2017.
4
The mechanisms and applications of T cell vaccination for autoimmune diseases: a comprehensive review.T 细胞疫苗接种治疗自身免疫性疾病的机制与应用:全面综述
Clin Rev Allergy Immunol. 2014 Oct;47(2):219-33. doi: 10.1007/s12016-014-8439-6.
5
Conservation of pathogenic TCR homology across class II restrictions in anti-ribonucleoprotein autoimmunity: extended efficacy of T cell vaccine therapy.抗核糖核蛋白自身免疫中 II 类限制的致病性 TCR 同源性的保守性:T 细胞疫苗治疗的疗效扩展。
J Immunol. 2014 May 1;192(9):4093-102. doi: 10.4049/jimmunol.1203197. Epub 2014 Mar 26.
6
Dendritic cells and the promise of antigen-specific therapy in rheumatoid arthritis.树突状细胞与类风湿关节炎抗原特异性治疗的前景。
Arthritis Res Ther. 2013 Feb 4;15(1):204. doi: 10.1186/ar4130.
7
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.T 细胞疫苗对复发进展型多发性硬化症患者有益:一项随机、双盲临床试验。
PLoS One. 2012;7(12):e50478. doi: 10.1371/journal.pone.0050478. Epub 2012 Dec 14.
8
Autologous T-cell vaccination for multiple sclerosis: a perspective on progress.用于治疗多发性硬化症的自体T细胞疫苗接种:进展展望。
BioDrugs. 2008;22(4):265-73. doi: 10.2165/00063030-200822040-00006.
9
Vaccines for multiple sclerosis: progress to date.用于治疗多发性硬化症的疫苗:迄今取得的进展。
CNS Drugs. 2008;22(3):175-98. doi: 10.2165/00023210-200822030-00001.
10
[Update on pathophysiologic and immunotherapeutic approaches for the treatment of multiple sclerosis].[多发性硬化症治疗的病理生理学及免疫治疗方法的最新进展]
Nervenarzt. 2007 Aug;78(8):883-911. doi: 10.1007/s00115-007-2261-9.